This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (23)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Herbert P. Stelling, MD; Henry N. Maimon, MD; Randall A. Smith, PhD; Richard I. Haddy, MD; Ronald J. Markert, PhD

Arch Intern Med. 1990;150(5):1001-1005.

Abstract
• The question of what the most accurate and efficient fecal occult blood testing method is for the early detection of pathological gastrointestinal tract bleeding continues to be intensely debated. In this prospective study, the following five uniquely different slide tests were investigated in 120 patients who underwent gastrointestinal tract investigation: (1) a combination monoclonal antibody guaiac test (Monohaem); (2) an immunologic assay, enzyme-linked immunosorbent assay, with (3) a highly sensitive guaiac test (Fecatwin S/Feca enzyme immunoassay), (4) a popular guaiac test (Coloscreen III) (comparable with Hemoccult II), and (5) Coloscreen III/VPI (ie, with vegetable peroxidase) inhibitor. Computerized data show efficiency values for detection of fecal occult blood by Coloscreen III-Fecatwin S-Monohaem combined, 93%; Coloscreen III-Monohaem combined, 91%; Monohaem, 87%; Coloscreen III/VPI, 82%; Coloscreen III, 79 percent; enzyme-linked immunosorbent assay, 77%; and Fecatwin S, 68%. Results of sensitivity, specificity, false-positive and false-negative test results, tests' predictive value, simplicity, and costs of tests in this clinically based study suggests that the concomitant use of the monoclonal, monospecific test for human hemoglobin and an appropriately sensitive guaiac test is a potentially valuable approach to mass screening and early detection of occult bleeding gastrointestinal tract pathology, including colorectal cancer.

(Arch Intern Med. 1990;150:1001-1005)

Author Affiliations
From the Departments of Family Practice (Drs Stelling and Haddy), Internal Medicine and Gastroenterology (Drs Maimon and Markert), and Microbiology and Immunology (Dr Smith), Wright State University School of Medicine, Dayton, Ohio.

Footnotes
Accepted for publication July 24,1989.

Reprint requests to Department of Family Practice, Wright State University School of Medicine, St Elizabeth Medical Center, 601 Edwin C. Moses Blvd, Dayton, OH 45408 (Dr Haddy).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neurology in Developing Countries: A Population Perspective
Singhal
Arch Neurol 1998;55:1019-1021.
FULL TEXT  

Fecal Occult Blood Screening for Colorectal Cancer
Van Dam et al.
Arch Intern Med 1995;155:2389-2402.
ABSTRACT  

A Comparative Study of Eight Fecal Occult Blood Tests and HemoQuant in Patients in Whom Colonoscopy Is Indicated
Gopalswamy et al.
Arch Fam Med 1994;3:1043-1048.
ABSTRACT  

Diagnostic Yield of a Positive Fecal Occult Blood Test Found on Digital Rectal Examination: Does the Finger Count?
Eisner and Lewis
Arch Intern Med 1991;151:2180-2184.
ABSTRACT  

Limitations of Fecal Occult Blood Testing
SAMPLINER
Arch Intern Med 1990;150:945-946.
ABSTRACT